The company is adding to a biologics manufacturing site in Frederick and building a facility in Gaithersburg for the development and supply of drugs for clinical trials.
The pharmaceutical development and manufacturing organization’s expansion to support clinical trials marks 10 years of operations in the Asian country.
The certificates cover all activities within the Grangemouth facility’s Helix building, which specializes in clinical and commercial drug substance manufacture and testing.
